EPISODE · Jul 29, 2026 · 2 MIN
Anvisa aprova registro de cinco novos medicamentos à base de semaglutida sintética
from Saúde · host CBN
A Anvisa aprovou nesta quarta-feira (29) o registro de cinco novos medicamentos à base de semaglutida sintética, substância que ganhou notoriedade nos últimos anos por estar presente em canetas utilizadas no tratamento do diabetes tipo 2 e da obesidade. Learn more about your ad choices. Visit megaphone.fm/adchoices
Embed this episode
NOW PLAYING
Anvisa aprova registro de cinco novos medicamentos à base de semaglutida sintética
0:00
2:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Saúde?
This episode is 2 minutes long.
When was this Saúde episode published?
This episode was published on July 29, 2026.
Can I download this Saúde episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!